Chinese companies retreat from U.S. listings as scrutiny mounts

NEW YORK (Reuters) – Chinese companies are deserting U.S. stock markets in record numbers as regulatory scrutiny mounts and the advantages of a U.S. listing slip away.

U.S. government investigations of suspect financial reports and battered share prices have for many Chinese companies wrecked the chances of raising new money in the United States and given them little reason so stay, China experts said.

“There’s very little in way of new capital flows to those companies, their valuations are low and they’re encountering significant headwinds in terms of regulatory oversight,” said James Feltman, a senior managing director at Mesirow Financial Consulting.